Part 1: The Wider Considerations in Translating Heart Failure Guidelines

Author(s): Pupalan Iyngkaran*, Andrew Wilson, James Wong, David Prior, David Kaye, David L Hare, Peter Bergin, Michael Jelinem

Journal Name: Current Cardiology Reviews

Volume 17 , Issue 5 , 2021

Article ID: e160721190003
Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Congestive Heart Failure (CHF) is an emerging epidemic. Within one generation, the medical community has learned much of CHF syndromes. It has two distinct mechanisms, systolic and diastolic abnormalities, to account for the common CHF presentation. It is complex as it challenges the available health care services, resource, and funding models in providing an equitable service across the health continuum. Despite the improvement in many cardiovascular diseases, some CHF outcomes like readmissions and costs have increased. The reinvigoration of evidence- based medicine, the development of health services models of care, and standardisation of disease processes with taxonomies have also occurred within the same time span. These processes, however, need to be linked with health policy as presented in white papers. In this paper, we explore achieving optimal CHF guideline-recommended outcomes as the science approaches realworld translation.

Keywords: Congestive heart failure, cost-efficacy, health services, taxonomy, white-papers, health systems.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2021
Published on: 07 January, 2021
Article ID: e160721190003
Pages: 9
DOI: 10.2174/1573403X16666210108104945
Price: $65

Article Metrics

PDF: 457